International Conferences

Recommended Conferences for Neuropathic Pain

Neuropathic Pain

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums.

Pain is associated with a huge range of injury and disease, Millions of people suffer from acute or chronic pain every year. The percentage of person suffering from migraines or severe headaches was inversely related to age. 20% adults aged of 18-44 years suffering from migraine or severe headache , 15% of adults aged 45-64, 7% of adults aged 65-74, and 6% of adults aged 75 and over. Adults aged 18-44 years were less likely to have experienced pain in the lower back during the 3 months prior to the interview compared with the older adults.Mainly there are three Neuropathic pain indications - painful diabetic neuropathy, post herpetic neuralgia and trigeminal neuralgia-including epidemiology, etiology, diagnosis, symptoms, pathophysiology and treatment. The impact of nerve fiber injury affects the change in nerve function both at the site of injury and also areas around the injury. some common causes which associates neuropathic pain includes various like: Alcoholism,  leg, hip problems and Amputation Back, Chemotherapy, Diabetes, Facial nerve problems, AIDS or HIV infection, Multiple sclerosis, Spine surgery and Shingles.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

In terms of geography, North America dominates the global Neuropathic pain market. The U.S. represents the largest market for neuropathic pain in North America, followed by Canada. In Europe, Germany, France, the U.K, Spain and Italy account for a significant share of the neuropathic pain market. The market in Asia is expected to expand at a significant rate over the next 5 years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness concerning neuropathic pain disorders and rise in geriatric population are also driving the growth of the market in the region Japan, India and China are expected to be the fastest growing neuropathic pain markets in Asia. The neuropathic pain market is expected to grow from US$2.6 billion in 2010 to reach $3.6 billion by 2020.

Neuropathic pain treatments expected to be launched in the coming years; the Neuropathic pain therapeutics market value - covering painful diabetic neuropathy, post herpetic neuralgia and trigeminal neuralgia - is forecast to increase from $2.68 billion in 2012 to $3.53 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 3.19%.

List of Best International Conferences:

• 5^th Neurology Congress, March 14-16, 2016 London, UK
• 2^nd Brain Disorders Conference, October 27-29, 2016 Chicago, USA
• 2^nd Neurological Disorders and Stroke Conference, April 28-30, 2016 Dubai, UAE
• 6^th Neurological Conference, May 19-20, 2016 San Antonio, USA
• 2^nd Parkinson’s Disease and Movement Disorders Conference, November 28-30, 2016 Chicago, USA
• 4^th Vascular Dementia Conference, June 30-July 2, 2016 Valencia, Spain
• 5^th Alzheimer’s Disease and Dementia Conference, September 29-Oct 1, 2016 London, UK
• 2^nd Adolescent Medicine and Child Psychology Conference, August 29- 31, 2016 Atlanta, USA
• 2^nd Depression, Anxiety and Stress Management Meeting, November 3-4, 2016 Valencia, Spain
• 2^nd Sleep Disorders Conference, November 28- 30, 2016 Chicago, USA
• EMRI Course Central Nervous System II

• Related Companies

• Medicinova

• Convergence Pharmaceuticals

• Glaxo-Smith Kline

• Durect

• Grünenthal

• Biogen

The World Health Organization (WHO) shows that 6.8 million people die every year as a result of neurological disorders, in Europe the economic cost of neurological diseases was estimated at about 139 billion euros in 2004. Total European 2010 cost of brain disorders was €798 billion and will grow to $480 billion by 2030

This page will be updated regularly.

This page was last updated on April 19, 2024